Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LMLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ECE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MDM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS13D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNRF2P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GYPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HINT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PANK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FPR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on